Latest Insider Transactions at Viking Therapeutics, Inc. (VKTX)
This section provides a real-time view of insider transactions for Viking Therapeutics, Inc. (VKTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Viking Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Viking Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 21
2024
|
J Matthew Singleton |
SELL
Open market or private sale
|
Direct |
5,700
-37.5%
|
$393,300
$69.72 P/Share
|
Aug 21
2024
|
J Matthew Singleton |
BUY
Exercise of conversion of derivative security
|
Direct |
5,700
+27.27%
|
$5,700
$1.19 P/Share
|
Aug 21
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.04%
|
$69,000
$69.9 P/Share
|
Aug 21
2024
|
Brian Lian President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.04%
|
$7,000
$7.77 P/Share
|
Aug 19
2024
|
J Matthew Singleton |
SELL
Open market or private sale
|
Direct |
16,000
-15.07%
|
$992,000
$62.52 P/Share
|
Aug 19
2024
|
J Matthew Singleton |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+38.55%
|
$48,000
$3.33 P/Share
|
Aug 19
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
112,870
-1.54%
|
$7,449,420
$66.27 P/Share
|
Aug 19
2024
|
Brian Lian President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
112,870
+4.37%
|
$790,090
$7.77 P/Share
|
Aug 14
2024
|
J Matthew Singleton |
SELL
Open market or private sale
|
Direct |
20,786
-34.88%
|
$1,184,802
$57.95 P/Share
|
Aug 14
2024
|
J Matthew Singleton |
BUY
Exercise of conversion of derivative security
|
Direct |
20,786
+40.7%
|
$166,288
$8.0 P/Share
|
Jul 30
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
115,859
-1.58%
|
$6,603,963
$57.85 P/Share
|
Jul 30
2024
|
Marianna Mancini Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,026
-2.39%
|
$1,027,482
$57.4 P/Share
|
Jul 30
2024
|
Greg Zante Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,136
-2.69%
|
$919,752
$57.79 P/Share
|
Jul 29
2024
|
Brian Lian President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
204,333
+3.97%
|
-
|
Jul 29
2024
|
Marianna Mancini Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,667
+4.05%
|
-
|
Jul 29
2024
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,334
+6.59%
|
-
|
May 03
2024
|
Greg Zante Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
66,756
-7.45%
|
$4,939,944
$74.87 P/Share
|
May 03
2024
|
Greg Zante Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,249
+6.51%
|
$136,996
$4.78 P/Share
|
May 01
2024
|
Marianna Mancini Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
281,425
-10.65%
|
$21,951,150
$78.38 P/Share
|
May 01
2024
|
Marianna Mancini Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
281,425
+9.65%
|
$1,688,550
$6.33 P/Share
|
Mar 27
2024
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,610
-7.42%
|
$1,378,630
$83.34 P/Share
|
Mar 27
2024
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,667
+12.39%
|
-
|
Mar 27
2024
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
153,948
-6.36%
|
$12,777,684
$83.34 P/Share
|
Mar 27
2024
|
Brian Lian President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
221,667
+8.39%
|
-
|
Mar 27
2024
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,610
-4.37%
|
$1,378,630
$83.34 P/Share
|
Mar 27
2024
|
Marianna Mancini Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,667
+7.69%
|
-
|
Mar 01
2024
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,093
-9.46%
|
$1,707,905
$85.22 P/Share
|
Mar 01
2024
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,667
+12.97%
|
-
|
Mar 01
2024
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,958
-4.64%
|
$1,441,430
$85.22 P/Share
|
Mar 01
2024
|
Marianna Mancini Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,667
+7.97%
|
-
|
Mar 01
2024
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
162,815
-6.89%
|
$13,839,275
$85.22 P/Share
|
Mar 01
2024
|
Brian Lian President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
221,667
+8.58%
|
-
|
Feb 09
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
45,000
-2.06%
|
$1,305,000
$29.9 P/Share
|
Feb 08
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
269,079
-2.32%
|
$7,265,133
$27.0 P/Share
|
Feb 08
2024
|
Brian Lian President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
189,079
+3.79%
|
$378,158
$2.94 P/Share
|
Feb 08
2024
|
Sarah Kathryn Rouan Director |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$700,000
$28.05 P/Share
|
Feb 08
2024
|
Sarah Kathryn Rouan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$200,000
$8.32 P/Share
|
Jan 31
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
85,000
-1.83%
|
$2,040,000
$24.7 P/Share
|
Jan 31
2024
|
Brian Lian President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
85,000
+3.49%
|
$85,000
$1.23 P/Share
|
Jan 30
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-1.52%
|
$805,000
$23.95 P/Share
|
Jan 30
2024
|
Brian Lian President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+1.5%
|
$35,000
$1.23 P/Share
|
Jan 19
2024
|
Sarah Kathryn Rouan Director |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$690,000
$23.05 P/Share
|
Jan 19
2024
|
Sarah Kathryn Rouan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$240,000
$8.32 P/Share
|
Jan 04
2024
|
Greg Zante Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-7.66%
|
$255,000
$17.9 P/Share
|
Jan 04
2024
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,872
-6.62%
|
$249,696
$18.58 P/Share
|
Jan 04
2024
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,199
-4.08%
|
$255,582
$18.58 P/Share
|
Jan 04
2024
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
39,552
-1.72%
|
$711,936
$18.58 P/Share
|
Jan 03
2024
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,122
-11.25%
|
$835,074
$17.4 P/Share
|
Jan 03
2024
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
98,334
+17.8%
|
-
|
Jan 03
2024
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,210
-6.82%
|
$836,570
$17.4 P/Share
|